BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17728268)

  • 21. Singaporean men's knowledge of cervical cancer and human papillomavirus (HPV) and their attitudes towards HPV vaccination.
    Pitts M; Smith A; Croy S; Lyons A; Ryall R; Garland S; Wong ML; Hseon TE
    Vaccine; 2009 May; 27(22):2989-93. PubMed ID: 19428910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors.
    Balamurugan A; Ahmed F; Saraiya M; Kosary C; Schwenn M; Cokkinides V; Flowers L; Pollack LA
    Cancer; 2008 Nov; 113(10 Suppl):2919-25. PubMed ID: 18980275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus (HPV) infection, cervical cancer and vaccination against HPV: a Nordic perspective.
    Kjaer SK
    Acta Obstet Gynecol Scand; 2007; 86(11):1286-9. PubMed ID: 17963055
    [No Abstract]   [Full Text] [Related]  

  • 24. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
    Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
    Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human papillomavirus vaccines: an update for gynecologists.
    Ault KA
    Clin Obstet Gynecol; 2008 Sep; 51(3):527-32. PubMed ID: 18677145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should an epidemiologist also have been awarded the 2008 Nobel Prize in Medicine?
    Morabia A
    J Epidemiol Community Health; 2009 Mar; 63(3):177-8. PubMed ID: 19218253
    [No Abstract]   [Full Text] [Related]  

  • 27. [Screening and vaccination: two synergic tools for the prevention of cervical cancer].
    Zaratti L; Senatore S; Franco E
    Ig Sanita Pubbl; 2007; 63(4):449-57. PubMed ID: 17912281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of human papillomavirus genotypes in women with cervical cancer in Slovenia.
    Jancar N; Kocjan BJ; Poljak M; Lunar MM; Bokal EV
    Eur J Obstet Gynecol Reprod Biol; 2009 Aug; 145(2):184-8. PubMed ID: 19477061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. One in four California adolescent girls have had human papillomavirus vaccination.
    Grant D; Kravitz-Wirtz N; Breen N; Tiro JA; Tsui J
    Policy Brief UCLA Cent Health Policy Res; 2009 Feb; (PB2009-3):1-6. PubMed ID: 19288623
    [No Abstract]   [Full Text] [Related]  

  • 30. Re: Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.
    Cai T; Mazzoli S; Bartoletti R
    J Natl Cancer Inst; 2008 Apr; 100(8):600; author reply 600-1. PubMed ID: 18398096
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical follow-up of women infected with human papillomavirus-16, either alone or with other human papillomavirus types: identification of different risk groups.
    Cottier O; Sahli R; Mihaescu A; De Grandi P; Boulvain M; Gerber S
    Am J Obstet Gynecol; 2009 Mar; 200(3):286.e1-6. PubMed ID: 19167699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papillomavirus and the HPV vaccine: are the benefits worth the risks?
    Knudtson M; Tiso S; Phillips S
    Nurs Clin North Am; 2009 Sep; 44(3):293-9. PubMed ID: 19683091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The new human papillomavirus (HPV) vaccine: pros and cons for pediatric and adolescent health.
    Thomas TL
    Pediatr Nurs; 2008; 34(5):429-31. PubMed ID: 19051848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. International correlation between human papillomavirus prevalence and cervical cancer incidence.
    Maucort-Boulch D; Franceschi S; Plummer M;
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):717-20. PubMed ID: 18349293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus: HPV information for clinicians.
    Centers for Disease Control and Prevention
    Ala Nurse; 2008 Dec-2009 Feb; 35(4):17-9. PubMed ID: 19166076
    [No Abstract]   [Full Text] [Related]  

  • 36. Screening and prevention: cervical cancer.
    Weinstein LC; Buchanan EM; Hillson C; Chambers CV
    Prim Care; 2009 Sep; 36(3):559-74. PubMed ID: 19616155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vaccination perspective against human papillomavirus and consequences for the screening of uterine cervical neoplasm].
    Delvenne P
    Bull Mem Acad R Med Belg; 2007; 162(10-12):483-8; discussion 489-90. PubMed ID: 18557390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EUROGIN 2007 roadmap on cervical cancer prevention.
    Monsonego J
    Vaccine; 2008 Mar; 26 Suppl 1():A1-3. PubMed ID: 18642466
    [No Abstract]   [Full Text] [Related]  

  • 39. Re: Human papillomavirus type 16 and 18 variants: race-related distribution and persistence.
    Sichero L; Trottier H; Ferreira S; Duarte-Franco E; Franco EL; Villa LL
    J Natl Cancer Inst; 2007 Apr; 99(8):653-4; author reply 654-5. PubMed ID: 17440166
    [No Abstract]   [Full Text] [Related]  

  • 40. Gynecological cancer: More evidence supporting human papillomavirus testing.
    Castle PE
    Nat Rev Clin Oncol; 2012 Feb; 9(3):131-2. PubMed ID: 22330684
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.